Otrivin Menthol Nasal Metered-Dose Spray

Fast & long lasting nasal decongestant that also relieves sinus pressure symptoms.

Unblocks your nose from 2 minutes.

Lasts up to 10 hours.

Aids sinus drainage.

Nasal Metered-Dose Spray: opalescent to clear, colourless to white solution with an odour of menthol and eucalyptol.

Otrivin Menthol Nasal Metered-Dose Spray:

Ingredients and Instructions for use

Ingredients: It contains the active ingredient xylometazoline hydrochloride that helps to relieve congestion through direct action on the blood vessels to produce capillary constriction.1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: 0,01 % m/v benzalkonium chloride. Excipients: disodium edetate, disodium phosphate dodecahydrate, eucalyptol (Cineole), menthol (Levomenthol), polyoxyl 40 hydrogenated castor oil (Cremophor RH 40), purified water, sodium chloride, sodium dihydrogen phosphate dihydrate, sorbitol 70 % (non-crystallising). Otrivin Menthol Metered-dose spray is for nasal administration only, in adults and children over 12 years of age: 1 application of the metered-dose spray into each nostril; a total of 3 applications a day is usually sufficient. Otrivin Menthol should be used after blowing the nose.

How to use Otrivin Menthol Nasal Metered-Dose Spray

Remove the protective cap. Before the first application prime the pump by actuating 4 times. Once primed, the pump will normally remain charged throughout regular daily treatment periods. If the spray is not ejected during the full actuation stroke, or if the product has not been used for longer than 7 days, the pump will need to be reprimed with 4 actuations. Be very careful not to spray in the eyes or mouth.

Insert the nozzle into the nostril and press once firmly on the spray head and breathe in at the same time. Then withdraw the nozzle before releasing pressure. Repeat the operation in the other nostril. Replace the protective cap.

The dosing spray ensures the Otrivin Menthol solution is well distributed over the surface of the nasal mucosa. The standardized valve with which it is fitted permits accuracy of dosage and precludes the possibility of unintentional overdosage.
Safety Information

Otrivin Menthol should be used with caution in patients showing a strong reaction to sympathomimetic agents, as evidenced by signs of insomnia, dizziness, tremor, cardiac dysrhythmias or elevated blood pressure. Otrivin Menthol should be used with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, epistaxis, phaechromocytoma, prostatic hypertrophy, monoamine oxidase inhibitors (MAOI) treatment or who have received them in the last two weeks (see INTERACTIONS).

Do not exceed the recommended dose, especially in children and in the elderly.

Otrivin Menthol should not be employed continuously for periods exceeding ten days: prolonged or excessive use may cause rebound congestion and/or atrophy of the nasal mucosa
How to store Otrivin Menthol Nasal Metered-Dose Spray

Store at or below 25 °C, protected from light and do not freeze.

KEEP OUT OF THE REACH OF CHILDREN.

Do not use the product after the expiry date shown on the packaging.

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manual.

S1 Otrivin Adult Drops. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1382.
S1 Otrivin Adult Nasal Metered-dose Spray. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1382.

* class-specific comparison (topical vs systemic decongestant)

Ref 1. Eccles R. Over the counter medicines for colds. In: Common Cold. Eccles R & Weber O, eds. Basel, Switzerland: Birkhäuser Verlag; 2009. (see reference here)

Ref 2. Eccles R, Eriksson M, Garreffa S, et al. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. 2008;22(5):491–6 (see reference here)

S1 OTRIVIN Menthol Nasal Metered-dose Spray. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01% m/v. Reg. no.: 31/16.1/0319.
S1 OTRIVIN Paed. Drops. Each 1 ml contains 0,5 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.
S1 OTRIVIN Paed. Nasal Metered-dose Spray. Each 1 ml contains 0, 5 mg of xylometazoline hydrochloride. Preservative: Benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.

Applicant: Haleon South Africa (Pty) Ltd. 11 Hawkins Avenue, Epping Industria 1, Cape Town,7450.

Company reg. no.: 2014/173930/07. For full prescribing information refer to the professional information approved by the medicines regulatory authority Always read label prior to use.

For any further information, including safety and adverse reactions, please contact the Haleon Hotline on 0800 007 018 or mystory.za@haleon.com.

This website is intended for residents of South & Southern African residents only.

* We do not supply our products directly to consumers. By selecting the Buy Now*/Try Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability.

PM-ZA-OTRI-21-00023